Skip to main content
Be The Investor
S&P 500
7,376.86+0.31%
After Hours7,398.84+0.30%
Nasdaq Composite
24,579.42+1.09%
After Hours24,905.36+1.33%
Dow Jones
51,285.73-0.46%
After Hours51,057.20-0.45%
Russell 2000
2,754.11+0.89%
After Hours2,779.38+0.92%
VIX
VIX
25.64-9.01%
Bitcoin
75,782.55+0.05%
Ethereum
2,237.70+0.11%
Solana
89.65-0.45%
Gold
4,079.60-0.82%
Silver
51.94-0.83%
Copper
6.238-0.52%
WTI Crude Oil
90.83+0.34%
US 10-Year Treasury Yield
4.859+0.45%
Home›Stocks›IAM
OverviewChartNewsFinancialsBusiness ModelCompetitorsStatisticsAnalysisEarningsValuationHoldersOptionsInsidersForecastCompareFAQ

Iambic Therapeutics Inc.

IAM
NASDAQUnited States flagUSReal-Time Price
$10.17USD
-1.47 (-12.63%)Today
$11.65+1.48 (+14.55%)Pre-MarketLast quote · Nov 6, 2026, 7:00 AM ET · Updates paused
BTI Score

BASIC required or higher

View pricing
BTI Fair Market Cap
$297.70M
Revenue-based (growth phase)
High Risk

Iambic Therapeutics Inc. (IAM) Forecast & Price Targets

Review available Iambic Therapeutics Inc. (IAM) analyst price targets and compare them with earnings and valuation. Analyst targets are separate from BTI scores; missing data is marked unavailable.

IAM stock forecast and analyst price targets

Analyst price targets estimate possible future share prices. They are separate from BTI scores and fair-value models. The highest and lowest targets describe the provider's range, not the probability of a bull or bear scenario.

Analyst targets are currently unavailable for IAM. BTI does not substitute example prices for missing targets.

How should I evaluate the IAM forecast?

Compare the targets with reported earnings, cash flow, valuation assumptions and company risks. A price target alone does not determine whether an investment is suitable.